SCHEMBL5705246

SCHEMBL5705246

CCCC(C)(CCCCC(=O)CCCCC(C)(CCC(O)O)c1ccccc1)c1ccccc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2C19 P33261 1/20 0.40
HIF1A Q16665 1/20 0.40
RIPK1 Q13546 1/20 0.35
CYP1A2 P05177 1/20 0.35
CYP2D6 P10635 1/20 0.35
KIF11 P52732 4/20 0.34
ASAH1 Q13510 2/20 0.33
CES2 O00748 1/20 0.33
CES1 P23141 1/20 0.33
HDAC8 Q9BY41 5/20 0.33
HDAC3 O15379 3/20 0.33
HDAC6 Q9UBN7 3/20 0.33
HDAC1 Q13547 2/20 0.33
HDAC2 Q92769 2/20 0.33
HDAC4 P56524 1/20 0.33
HDAC7 Q8WUI4 1/20 0.33
HDAC10 Q969S8 1/20 0.33
HDAC11 Q96DB2 1/20 0.33
HDAC9 Q9UKV0 1/20 0.33
HDAC5 Q9UQL6 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5705353 0.99 CYP2C19 (0.39) CYP2C19HIF1ARIPK1CYP1A2CYP2D6
SCHEMBL5705432 0.96 CYP2C19 (0.41) CYP2C19HIF1ARIPK1CYP1A2CYP2D6
SCHEMBL7021868 0.80 CYP2C19 (0.41) CYP2C19HIF1ARIPK1CYP1A2CYP2D6
SCHEMBL3280257 0.80 CYP2C19 (0.53) CYP2C19HIF1ACYP1A2CYP2D6HDAC8
SCHEMBL7027001 0.79 CYP2C19 (0.40) CYP2C19HIF1AKIF11ASAH1CES2
SCHEMBL3281096 0.79 CYP2C19 (0.47) CYP2C19HIF1ACYP1A2CYP2D6HDAC8
SCHEMBL3280203 0.79 CYP2C19 (0.47) CYP2C19HIF1ACYP1A2CYP2D6KIF11
SCHEMBL3278666 0.79 CYP2C19 (0.51) CYP2C19HIF1ACYP1A2CYP2D6HDAC8
SCHEMBL3286528 0.77 CYP2C19 (0.46) CYP2C19HIF1ACYP1A2CYP2D6CES2
SCHEMBL3279434 0.77 CYP2C19 (0.46) CYP2C19HIF1ACYP1A2CYP2D6CES2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1326822-A2 KETONE COMPOUNDS AND COMPOSITIONS FOR CHOLESTEROL MANAGEMENT AND RELATED USES Esperion Therapeutics Inc. (US) 2003-07-16 EP claimed
WO-2002030860-A2 KETONE COMPOUNDS AND COMPOSITIONS FOR CHOLESTEROL MANAGEMENT AND RELATED USES ESPERION THERAPEUTICS, INC. (US) 2002-04-18 WO claimed
EP-1701931-A1 KETONE COMPOUNDS AND COMPOSITIONS FOR CHOLESTEROL MANAGEMENT AND RELATED USES Esperion Therapeutics, Inc. (US) 2006-09-20 EP disclosed
WO-2005068412-A1 KETONE COMPOUNDS AND COMPOSITIONS FOR CHOLESTEROL MANAGEMENT AND RELATED USES ESPERION THERAPEUTICS, INC. (US) 2005-07-28 WO disclosed
EP-1326822-A2 KETONE COMPOUNDS AND COMPOSITIONS FOR CHOLESTEROL MANAGEMENT AND RELATED USES Esperion Therapeutics Inc. (US) 2003-07-16 EP disclosed
WO-2002030860-A9 KETONE COMPOUNDS AND COMPOSITIONS FOR CHOLESTEROL MANAGEMENT AND RELATED USES ESPERION THERAPEUTICS INC (US) 2003-02-20 WO disclosed
WO-2002030860-A2 KETONE COMPOUNDS AND COMPOSITIONS FOR CHOLESTEROL MANAGEMENT AND RELATED USES ESPERION THERAPEUTICS, INC. (US) 2002-04-18 WO disclosed